Skip to main content
Back to Initiatives

Lancet Haematology Commission on SCD

Systemic Problem

Global policy on sickle cell disease suffers from fragmented evidence and weak patient inclusion in priority-setting.

Existing Landscape

Existing policy frameworks often lack participatory evidence, governance analysis, and implementation perspectives.

What We Build

We contribute participatory evidence frameworks, governance analysis, and implementation perspectives to the Lancet Haematology Commission.

Our Role

Convivens Lab contributes as a methodological and infrastructural partner to the Commission.

Evaluation Strategy

We assess policy influence and uptake of participatory methods.

Opportunities

The Commission welcomes input from stakeholders worldwide.